From:  Circadian rhythm modulation in metabolic disease: targeting clock genes for obesity and insulin resistance

 Pharmacologic interventions targeting circadian pathways.

Drug/ClassTargetEffect on metabolism
REV-ERB agonistsCLOCK/BMAL1Reduces hepatic steatosis
MelatoninSCN/Peripheral clocksImproves insulin sensitivity
SIRT1 activatorsCLOCK regulationEnhances energy expenditure
NobiletinPER/CRY modulationReduces adiposity

BMAL1: brain and muscle ARNT-like 1; CLOCK: circadian locomotor output cycles kaput; CRY: cryptochrome; PER: period gene; REV-ERB: reverse erythroblastosis virus alpha/beta (nuclear receptors); SCN: suprachiasmatic nucleus; SIRT1: sirtuin 1.